Scientist, Neurobiology

Each day, the lives of more than 2 billion people across the globe are impacted by chronic diseases. Moreover, the economic burden on society of treating chronic disease is spinning out of control. Today, this dire situation appears unlikely to change as >95% of global healthcare costs are spent on treating rather than preventing chronic diseases. Etiome is a privately held early‑stage company that is applying advanced biological and computational platforms to discover breakthroughs in detection of and intervention against the etiologies that drive progression from health to disease.

Our goal is to leverage our proprietary platforms to disrupt the current approach of treating chronic disease after symptoms onset. We endeavor to provide true health care rather than sick care to individuals that are at risk of progressing to disease.

Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID‑19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture.

Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at

Etiome is seeking a highly motivated and experienced scientist focusing on neurobiology.

• Planning, executing, and analyzing hands‑on, wet‑bench experiments involving primary and iPSC‑derived neural cell types including but not limited to MEA studies, sc/snRNAseq studies, immunohistological studies, etc.
• Culturing and maintaining primary and iPSC‑derived cell cultures, including co‑cultures and organoids
• Planning, executing, and analyzing in vivo studies focused on neurobiology
• Analyzing and interpreting single cell/single nuclei RNAseq studies
• Interpreting, organizing, and presenting biological data

• Expertise in neuroscience and neurodegenerative disorders, preferably Alzheimer's Disease
• Ph.D. in neurobiology, biology, molecular biology, cellular biology or similar with 0 to 4 years of experience post Ph.D.
• Hands on experience with in vitro assays using iPSC‑derived neurons and relevant co‑cultures, microelectrode array technology, beta amyloid and/or tau seeding assays, etc.
• Hands on experience with Alzheimer’s Disease relevant in vivo mouse models
• Experience with bulk and single cell/single nuclei RNAseq data generation and data analysis workflows
• Strong organization and time management skills
• Strong oral and written communication skills
• Attention to detail and good documentation practices

Flagship Pioneering is a bioplatform innovation company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID‑19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture.

Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies.…